GlassScriptPhysician profile
Debra D Wilhite
NPI 1992775878
$930.50
in general payments reported to CMS, 2019-2025
18 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.01 · 2022: $282 · 2023: $89.05 · 2024: $169 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.91 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $166.07 | 2024-2025 | Breztri, Farxiga, Lokelma |
| Astellas Pharma US INC | $134.58 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.53 | 2024-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $85.08 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $78.43 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $67.15 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $53.96 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $38.89 | 2022-2023 | |
| Boston Scientific Corporation | $38.13 | 2025 | Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $29.28 | 2025 | Navitor |
| Philips North America LLC | $24.32 | 2025 | Ecc Solutions |
| E.R. Squibb & Sons, L.L.C. | $19.14 | 2025 | Eliquis |
| Xeris Pharmaceuticals, INC. | $18.88 | 2023 | Gvoke Hypopen |
| Pfizer INC. | $18.04 | 2025 | |
| Glaxosmithkline, LLC. | $15.78 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $15.42 | 2025 | |
| Exact Sciences Corporation | $15.36 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $12.46 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Wilhite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.